Your Mounjaro price guide · October 2026
Rowe GLP1: What You Are Probably Looking For (October 2026)
"Rowe GLP1" is not a medicine or a product. EverydayMeds is a UK online pharmacy and is not connected to anyone using that name. If you want the medicine itself, GLP-1 treatments such as Mounjaro are prescription-only and need a consultation.
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Compare UK Mounjaro Prices
Prices checked 10 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
"Rowe GLP1" is a surname plus a drug class, not a treatment. It usually refers to investment notes, professional profiles and overseas guides.
-
EverydayMeds is a GPhC-registered UK pharmacy (9012878) and is not affiliated with any investment firm, coach or clinician named Rowe.
-
GLP-1 medicines are prescription-only in the UK and are used alongside a reduced-calorie diet and increased physical activity.
-
Mounjaro (tirzepatide) activates both GIP and GLP-1 receptors, so it is described as dual-acting rather than a pure GLP-1 medicine.
-
Digestive side effects are the most common. Severe, persistent stomach pain, upper right abdominal pain with fever or yellowing of the skin or eyes, or signs of a severe allergic reaction need immediate medical help.
In this guide
01 · The short answer
What does "rowe glp1" actually mean?
The phrase combines a surname and a drug class. Nothing sold or prescribed carries the name. Material using it falls into a few groups, and knowing which group you want saves time.
Some are investment commentary. Asset managers have published views on how GLP-1 receptor agonists could affect food and drink, insurance, medical technology and surgery. That is market analysis about industries, not health advice for individuals. Others are professional profiles, where a clinician or coach with that surname writes about supporting people on GLP-1 treatment, often with a focus on muscle, nutrition or women's health. A further group are overseas guides to weight-loss drugs that do not describe how the UK system works.
We are none of these. We are a GPhC-registered UK online pharmacy (registration 9012878), and we write about the medicines, not the markets.
| If you meant… | What it usually is | Where to go |
|---|---|---|
| Investment views on GLP-1 drugs | Market commentary on sectors affected by weight-loss medicines | The asset manager's own published research. It is not medical advice. |
| A named clinician or coach | A personal professional profile or social post about GLP-1 support | Their own page. We cannot speak for any individual. |
| A guide from another country | Information shaped by a different regulator and different products | UK product information and a UK prescriber. |
| The medicine itself | A prescription-only injection or tablet used with diet and activity | A consultation with a GPhC-registered prescriber, such as through our weight loss clinic. |
02 · Your decision
Is GLP-1 treatment relevant to you?
It may be if you are an adult considering medically supported weight management. Mounjaro is licensed in the UK for weight management in adults and for type 2 diabetes, and it is used alongside a reduced-calorie diet and increased physical activity.1 It is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. Individual results vary.
NHS access exists but is phased. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions). Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.46
If you want to see what private treatment looks like, the Mounjaro pen page has the free consultation. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and all six doses are in stock.
Related guides: Pmos glp1 and Mounjaro and hrv.
Related guide: Glp1 ras.
03 · What GLP-1 means
What GLP-1 medicines are
GLP-1 is a natural gut hormone that helps regulate appetite and blood sugar. Medicines that copy its action are called GLP-1 receptor agonists.
Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.1
Other medicines in the wider family include semaglutide, sold as Wegovy for weight management, which is a once-weekly injection with a dose ladder of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg. Liraglutide, sold as Saxenda, is a daily injection supplied at 6mg/ml. Your prescriber decides which medicine suits you.
04 · Is tirzepatide GLP-1?
Is Mounjaro a GLP-1 medicine?
Mounjaro acts on GLP-1 receptors, but it also acts on a second hormone receptor. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.1
In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet. This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).1
So when a headline says "GLP-1 drugs", it may be describing the whole class loosely. The exact medicine matters for dosing, side effects and what a prescriber can advise.
05 · What trials show
What the main Mounjaro trial reported
In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone. These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.2
At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.2
Trial averages do not predict your own result. Your prescriber will talk through realistic expectations and review how you respond over time.
06 · Side effects and safety
Side effects and when to seek help
Most side effects are digestive and settle with time. Like all medicines, Mounjaro can cause side effects, and most are digestive. The most common — affecting more than 1 in 10 people — are nausea, diarrhoea, vomiting, constipation and abdominal discomfort. Common effects (up to 1 in 10) include indigestion, reduced appetite, dizziness, reflux, burping, hair shedding and injection-site reactions. Side effects are most likely when starting treatment or moving up a dose, and for most people they ease within days to a few weeks as the body adjusts.13
Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.13
For any new symptom that continues, speak to your prescriber or pharmacist, and you can report suspected side effects through the MHRA Yellow Card scheme.19
07 · Contraception and storage
Contraception and storing the pen
If you use the contraceptive pill, Mounjaro matters for you. Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase. This applies to the pill only — implants, coils and injections are unaffected.17
Storage is straightforward. Keep Mounjaro pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use — useful for short trips — and must then be thrown away. Do not use a pen that has been above 30°C or has been frozen. Keep the pen cap on to protect it from light.1
08 · Judging GLP-1 sources
How to judge what you read about GLP-1
Check who is writing and why. An investment note is written for investors and describes sectors, not patients. A clinician's profile reflects one person's practice. Neither replaces a consultation with a prescriber who has your health history.
Look for the regulator. A UK pharmacy should appear on the GPhC register, and ours does under 9012878. Be wary of anyone offering to supply a prescription medicine without a consultation or prescription. Counterfeit and unregulated products are a real risk, and the MHRA publishes alerts about them.7
Watch for dramatic weight-loss claims and for anything that promises specific results. Real trial figures always name the trial and say that individual results vary.
Be careful with supplements marketed as natural alternatives. They are low-cost supplements with no clinical oversight, and dosing is not standardised. Our page on berberine with GLP-1 explains why you should speak to a pharmacist or prescriber before combining anything with a prescription medicine.
09 · Related questions
Other GLP-1 topics
- PCOS and GLP-1 treatment for people asking how weight-management medicines relate to hormonal conditions.
- Mounjaro and heart rate variability for people who track their health with wearables.
- Elevate and GLP-1 for people comparing programmes and brand names.
Ongoing monthly reviews, dose titration and side-effect support from the prescribing team are part of our aftercare.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamWhat is "rowe glp1"?
Is EverydayMeds connected to anyone called Rowe?
Is Mounjaro a GLP-1 medicine?
Can I get a GLP-1 medicine on the NHS?
What are the most common side effects?
Does Mounjaro affect the contraceptive pill?
How do I start treatment with a UK pharmacy?
Should I rely on investment commentary for health decisions?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 7 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022;387:205–216
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS England — Weight management injections: rollout guidance
- MHRA — guidance on contraception with GLP-1/GIP medicines; counterfeit medicine alerts and Yellow Card scheme
- Mounjaro KwikPen — Patient Information Leaflet (emc)
- MHRA Yellow Card scheme — report a side effect
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


